Skin Autofluorescence in Gestational Diabetes Mellitus, Compared to Normoglycaemic Gestation

Skin Autofluorescence in Gestational Diabetes Mellitus, Compared to Normoglycaemic Gestation - Skin autofluorescence in gestational diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34889

Enrollment

Registered

2010-02-01

Start date

2010-02-23

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Pregnant patients (non-diabetic or GDM) -Written informed consent -Knowledge of Dutch - Planned for a screening challenge test (50 gr)

Exclusion criteria

Exclusion criteria: -renal failure (GFR

Design outcomes

Primary

Measure	Time frame
SAF level of GDM women compared to non-diabetic pregnant women	—

Secondary

Measure	Time frame
laboratory assessments: glucose, HbA1c, fructosamine	—

Countries

Netherlands

Outcome results